Interaction Checker
No Interaction Expected
Dolutegravir/Lamivudine (DTG/3TC)
Daunorubicin
Quality of Evidence: Very Low
Summary:
Coadministration has not been studied but based on metabolism and clearance a clinically significant interaction is unlikely. No interaction is expected with dolutegravir. A clinical study reported that antiretroviral regimens containing lamivudine had no effect on the pharmacokinetics of liposomal daunorubicin.
Description:
View all available interactions with Dolutegravir/Lamivudine (DTG/3TC) by clicking here.
Copyright © 2026 The University of Liverpool. All rights reserved.